• Amiloride (MK-870): Translational Leverage in Sodium Channel

  2026-05-29

  Explore the mechanistic underpinnings and translational strategies for using Amiloride (MK-870) in sodium channel and endocytosis research. This thought-leadership article integrates recent evidence, practical workflow guidance, and a forward-looking vision for its impact across disease models, positioning APExBIO’s reagent as a cornerstone for next-generation studies.

• Dual Luciferase Reporter Gene System: Advancing lncRNA Resea

  2026-05-29

  Explore how the Dual Luciferase Reporter Gene System enables precise gene expression regulation studies, with a special focus on lncRNA-mediated pathways. Discover unique insights into assay selection informed by recent breakthroughs in stem cell biology.

• Cy5 TSA Fluorescence System Kit: Precision Signal Amplificat

  2026-05-28

  The Cy5 TSA Fluorescence System Kit transforms immunochemistry by enabling ultra-sensitive, high-resolution detection of low-abundance targets. Its robust, HRP-catalyzed tyramide deposition workflow empowers researchers to capture spatially-resolved cellular events with confidence—even in challenging tissue contexts.

• Cefepime (BMY-28142) in CNS Infection Models: Protocols & In

  2026-05-28

  Cefepime (BMY-28142) stands out for its robust, broad-spectrum antimicrobial activity and unique blood-brain barrier penetration, enabling advanced research into central nervous system infections and resistance mechanisms. This guide translates recent resistance modeling breakthroughs into actionable protocols, troubleshooting, and workflow enhancements for maximizing research impact.

• NADH in Applied Research: Protocols and Pitfalls in Redox Mo

  2026-05-27

  Unlock the full potential of NADH (Reduced-form Nicotinamide Adenine Dinucleotide) in modeling mitochondrial dysfunction and redox imbalance. This guide delivers actionable protocols, troubleshooting strategies, and advanced workflows—directly informed by landmark DKD research and peer-reviewed assay innovations.

• Abiraterone Acetate: Enhancing CYP17 Inhibitor Workflows in

  2026-05-27

  Harnessing Abiraterone acetate as a potent CYP17 inhibitor transforms prostate cancer research by enabling precise androgen pathway modulation in advanced 3D culture models. This guide delivers protocol strategies, troubleshooting insights, and evidence-led innovations for translational and preclinical studies.

• Dual Luciferase Reporter Gene System: Sensitive Gene Regulat

  2026-05-26

  The Dual Luciferase Reporter Gene System enables highly sensitive, normalized quantification of gene expression regulation in mammalian cells. By leveraging firefly and Renilla luciferase substrates, the K1136 kit from APExBIO facilitates robust bioluminescence reporter assays for transcriptional regulation studies. Its direct-addition workflow supports reproducible, high-throughput luciferase detection and accurate normalization.

• Epalrestat: Aldose Reductase Inhibitor for Neuroprotection R

  2026-05-26

  Epalrestat stands out as a high-purity aldose reductase inhibitor, uniquely enabling advanced oxidative stress and neurodegeneration research. Its robust KEAP1/Nrf2 pathway activation profile and translation-ready solubility streamline workflows for Parkinson’s and diabetic complication models.

• HOXC8 Suppresses Pyroptosis in NSCLC by Repressing Caspase-1

  2026-05-25

  This study uncovers the mechanism by which HOXC8 regulates cell death in non-small cell lung carcinoma (NSCLC), demonstrating that HOXC8 represses caspase-1 expression and thereby prevents pyroptosis. These findings clarify the epigenetic control of inflammatory cell death in lung cancer and highlight therapeutic opportunities for targeting pyroptotic pathways.

• Targeting Fructose Metabolism in Cancer: Insights and Tools

  2026-05-25

  The reference study systematically reviews the role of fructose metabolism in cancer malignancy, highlighting how overactivation of the polyol pathway and related transporters contributes to tumor progression. These findings suggest that targeting aldose reductase and other key enzymes may offer new therapeutic avenues for aggressive cancers, and inform method selection in metabolic research.

• tFUS Mitigates Post-Stroke Neuroinflammation via SHP2 Pathwa

  2026-05-24

  This study reveals that transcranial focused ultrasound stimulation (tFUS) alleviates NLRP3-driven neuroinflammation after ischemic stroke by regulating the Nespas/miR-383-3p/SHP2 signaling axis in microglia. These findings clarify a mechanistic basis for tFUS-mediated neuroprotection and suggest new strategies for targeting SHP2 in neuroinflammatory disease models.

• Prednisone in Research: Applied Workflows and Troubleshootin

  2026-05-23

  Prednisone, a synthetic corticosteroid, empowers immunology and neurodegeneration research through precise cell cycle arrest and apoptosis induction workflows. This article delivers optimized protocols, advanced troubleshooting, and practical integration of metabolomics insights to maximize reproducibility and impact.

• Epalrestat: Benchmark Aldose Reductase Inhibitor for Researc

  2026-05-22

  Epalrestat is a high-purity aldose reductase inhibitor with demonstrated efficacy in polyol pathway inhibition and KEAP1/Nrf2 pathway activation. Its unique profile supports advanced oxidative stress and diabetic neuropathy research. This article details its biological rationale, mechanism, evidence, and protocol parameters for robust scientific application.

• Angiotensin Peptides Enhance SARS-CoV-2 Spike–AXL Binding

  2026-05-22

  This study demonstrates that naturally occurring angiotensin peptides, including Angiotensin 1/2 (1-6), potentiate the binding of the SARS-CoV-2 spike protein to the AXL receptor, suggesting a new mechanistic link between the renin-angiotensin system and viral entry. These findings provide a refined molecular context for cross-domain research in cardiovascular, renal, and infectious disease settings.

• HyperFluor 488 Goat Anti-Human IgG Antibody: Workflow, Use,

  2026-05-21

  The HyperFluor™ 488 Goat Anti-Human IgG (H+L) Antibody sets a new standard for sensitive, multiplexed immunodetection in translational research. Its optimized Alexa Fluor 488 conjugation delivers robust signal amplification, reproducibility, and flexibility across Western blot, immunofluorescence, immunohistochemistry, and flow cytometry workflows.

16251 records 1/1084 page Next 12345 下5页 Last page